Marsden PD, 1986. Mucosal leishmaniasis (“espundia” Escomel, 1991). R Soc Trop Med Hyg 80 :859–876.
Barral A, Pedral-Sampaio D, Grimaldi G Jr, Momen H, Mcmahon-Pratt D, Jesus AR, Almeida R, Badaró R, Barral-Neto M, Carvalho EM, Johnson WD, 1991. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44 :536–546.
Zajtchuk JT, Casler JD, Netto EM, Grogl M, Neafie RC, Hessel CR, De Magalhaes AV, Marsden PD, 1999. Mucosal leishmaniasis in Brazil. Laryngoscope 99 :925–939.
Herwaldt BL, 1999. Leishmaniasis. Lancet 354 :1191–1199.
Manzur A, Bari AE, 2006. Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis. Dermatol Online J 12 :2.
Marsden PD, Lessa HA, Oliveira MR, Romero GA, Marotti JG, Sampaio RN, Barral A, Carvalho EM, Cuba CC, Magalhães AV, Macêdo VO, 1998. Clinical observations of unresponsive mucosal leishmaniasis. Am J Trop Med Hyg 59 :543–545.
Grogl M, Thomasin TN, Franke ED, 1992. Drug resistence in leishmaniasis; its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 47 :117–126.
Costa JML, Netto EM, Masden PD, 1986. Acute airway obstruction due to oedema of the larynx following antimony therapy in mucosal leishmaniasis. Rev Soc Bras Med Trop 19 :109.
da Silva ACT, Cupolillo E, Volpini AC, Almeida R, Romero GAS, 2006. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil. Trop Med Int Health 11 :1388–1398.
Llanos-Cuentas EA, Marsden PD, Cuba CC, Barreto AC, Campos M, 1984. Possible risk factors in development of mucosal lesions in leishmaniasis. Lancet 2 :295.
Oliveira CI, Báfica A, Oliveira F, Favali CB, Correa T, Freitas LAR, Nascimento E, Costa JM, Barral A, 2003. Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin Infect Dis 37 :149–153.
Oliveira JG, Novais FO, de Oliveira CI, da Cruz Junior AC, Campos LF, da Rocha AV, Boaventura V, Noronha A, Costa JM, 2005. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop 945 :5–59.
Szeinbach SL, Harpe SE, Williams PB, Elhefni H, 2008. Testing for allergic disease: parameters considered and test value. BMC Fam Pract 9 :47.
Younis RT, Anand VK, Davidson B, 2002. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope 112 :224–229.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 747 | 626 | 20 |
Full Text Views | 223 | 10 | 0 |
PDF Downloads | 46 | 7 | 0 |
An increase in mucocutaneous leishmaniasis (ML) cases in northern (Brazil) motivated this study. In 44 ML patients with clinical diagnosis, only 13 parasitologically confirmed cases exhibited mucosal lesion suggestive of ML. Other conditions involving nasal manifestations are frequently confounded with ML. Therefore, otorhinolaryngologic examination is important in the clinical management of ML.
Marsden PD, 1986. Mucosal leishmaniasis (“espundia” Escomel, 1991). R Soc Trop Med Hyg 80 :859–876.
Barral A, Pedral-Sampaio D, Grimaldi G Jr, Momen H, Mcmahon-Pratt D, Jesus AR, Almeida R, Badaró R, Barral-Neto M, Carvalho EM, Johnson WD, 1991. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44 :536–546.
Zajtchuk JT, Casler JD, Netto EM, Grogl M, Neafie RC, Hessel CR, De Magalhaes AV, Marsden PD, 1999. Mucosal leishmaniasis in Brazil. Laryngoscope 99 :925–939.
Herwaldt BL, 1999. Leishmaniasis. Lancet 354 :1191–1199.
Manzur A, Bari AE, 2006. Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis. Dermatol Online J 12 :2.
Marsden PD, Lessa HA, Oliveira MR, Romero GA, Marotti JG, Sampaio RN, Barral A, Carvalho EM, Cuba CC, Magalhães AV, Macêdo VO, 1998. Clinical observations of unresponsive mucosal leishmaniasis. Am J Trop Med Hyg 59 :543–545.
Grogl M, Thomasin TN, Franke ED, 1992. Drug resistence in leishmaniasis; its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 47 :117–126.
Costa JML, Netto EM, Masden PD, 1986. Acute airway obstruction due to oedema of the larynx following antimony therapy in mucosal leishmaniasis. Rev Soc Bras Med Trop 19 :109.
da Silva ACT, Cupolillo E, Volpini AC, Almeida R, Romero GAS, 2006. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil. Trop Med Int Health 11 :1388–1398.
Llanos-Cuentas EA, Marsden PD, Cuba CC, Barreto AC, Campos M, 1984. Possible risk factors in development of mucosal lesions in leishmaniasis. Lancet 2 :295.
Oliveira CI, Báfica A, Oliveira F, Favali CB, Correa T, Freitas LAR, Nascimento E, Costa JM, Barral A, 2003. Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin Infect Dis 37 :149–153.
Oliveira JG, Novais FO, de Oliveira CI, da Cruz Junior AC, Campos LF, da Rocha AV, Boaventura V, Noronha A, Costa JM, 2005. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop 945 :5–59.
Szeinbach SL, Harpe SE, Williams PB, Elhefni H, 2008. Testing for allergic disease: parameters considered and test value. BMC Fam Pract 9 :47.
Younis RT, Anand VK, Davidson B, 2002. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope 112 :224–229.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 747 | 626 | 20 |
Full Text Views | 223 | 10 | 0 |
PDF Downloads | 46 | 7 | 0 |